Is Animal Health a core business?
Animal Health is one of our two business areas. Although small relative to our Human Pharmaceuticals business, it is growing significantly above market and showing increasingly improved profitability. Boehringer Ingelheim’s Animal Health business holds an international market share of 3%, putting it in the 9th position in the market. Our research-driven expertise and human pharmaceuticals excellence ensures to contribute to a safe and nutritious food supply and helps companion animals to live a longer and healthier life. We plan to focus more on preventative solutions and aim to become world market leader with our swine biologicals.
